Amsterdam, 11 september 2015 – Cognizant kondigt aan dat Iluminage Beauty, Inc., leverancier van apparaten voor schoonheidsverzorging aan huis, het
MedVantage™-platform van Cognizant gebruikt om proactief de feedback van klanten aan te pakken en de kwaliteit en prestaties van producten beter te beheren.
Iluminage Beauty, een samenwerkingsverband tussen Unilever Ventures en Syneron, ontwerpt, ontwikkelt en distribueert producten afkomstig van professionele medische esthetische apparatuur voor onder andere huidverjonging, ontharing en acnebehandeling.
Kijk hieronder voor het volledige Engelstalige bericht.
Iluminage Beauty Uses Cognizant’s MedVantage Cloud Platform to Improve ‘At-Home’ Aesthetic Care Experience
Cognizant (NASDAQ: CTSH) today announced that Iluminage Beauty, Inc., a leader in at-home beauty care devices, has deployed the Cognizant
MedVantage™ platform to proactively address customer feedback and better manage product quality and performance.
Iluminage Beauty, a joint venture between Unilever Ventures and Syneron, designs, develops and distributes at-home products derived from professional medical aesthetic devices for skin rejuvenation, hair removal, acne treatment and others.
Cognizant’s cloud-based MedVantage solution will enable Iluminage to investigate complaints from across North America more effectively and efficiently, and create reports for enhanced regulatory compliance. It will help Iluminage improve customer and stakeholder responsiveness and accelerate decision-making by enabling separate handling of safety and non-safety complaints, delivering advanced analytics and providing a consistent view of data from multiple systems delivered by powerful real-time dashboards that can be accessed from anywhere.
Developed on the Salesforce1 platform, MedVantage is integrated with Iluminage’s Salesforce.com customer relationship management (CRM) platform and compliant with the FDA’s 21 CFR Part 11 Rule on electronic records.
“Iluminage is the new intelligence in beauty, architects of high-tech, ground breaking devices, treatments and textiles bringing tomorrow’s technology in to the hands of consumers at home,” said Bo Kim, Vice President Regulatory and Compliance at Iluminage. “Our objective is to deliver the highest level of at-home beauty care experience to our customers in North America and all over the world. With Cognizant MedVantage, our customer support and investigation teams can take a proactive approach to monitoring our quality and performance. It will help us better understand and improve our at-home beauty solutions while maintaining a high level of regulatory compliance through streamline reporting.”
“With the rapid growth of at-home aesthetic devices once only available in professional environments, Iluminage is leveraging the power of the cloud with MedVantage to improve customer experience and ensure that complaints are effectively addressed,” said Shankar Narayanan, Vice President and Global Markets Leader of the Life Sciences practice at Cognizant. “We developed MedVantage as a turnkey solution on Salesforce1 in order to provide the highest levels of integration with a leading cloud and CRM platform and enable companies to continue transforming into digital enterprises and be as agile and innovative as possible.”
About Iluminage Beauty Inc.
Iluminage Beauty Inc. is a joint venture between Unilever Ventures and Syneron Medical. As architects of high-tech, groundbreaking treatments, textiles and devices, the company's portfolio of products are based upon clinically proven technologies derived from professional medical and aesthetic treatments, enabling consumers to achieve professional results at home. The iluminage brand portfolio includes the iluminage SKIN SMOOTHING LASER™, which launched in spring 2014, becoming the first at-home laser device FDA-cleared to reduce fine lines and wrinkles around the eyes and mouth; iluminageTOUCH, the first and only at-home hair removal device clinically proven and FDA-cleared to be safe and effective for all skin types and tones, as well as the widest range of hair colors; iluminage PRECISE TOUCH, a compact hair removal device intended for use on targeted treatment areas including the upper lip, underarms and bikini area; and intelligent textiles—pillowcases and eye masks infused with patented copper technology, which delivers overnight anti-aging care to help maintain the skin’s youthful appearance.
About Cognizant's Healthcare and Life Sciences Practice
Cognizant's Healthcare and Life Sciences practice, which includes the TriZetto software portfolio, is committed to helping change millions of lives for the better by partnering with clients to build solutions to healthcare challenges, continually improve the way they do business, set the pace in clinical development, strengthen their regulatory infrastructure, and increase competitiveness. With over $3.5 billion in annualized revenue, Cognizant’s healthcare practice is ranked among the top 5 on the Healthcare Informatics Top 100. Cognizant serves 28 of the top 30 global pharmaceutical companies, 16 of the top 20 health plans in the U.S., 3 of the top 5 pharmacy benefit management companies in the U.S., 9 of the top 10 biotech companies, and 12 of the top 15 medical device companies. With a large team of dedicated professionals including doctors, pharmacologists, physicians, biomedical engineers, pharmacists, biostatisticians, medical writers, and GxP consultants, the practice provides domain-aligned consulting, IT, business process, software and as-a-service solutions globally.
Over Cognizant
Cognizant (NASDAQ: CTSH) is een vooraanstaande dienstverlener in informatietechnologie, consultancy en business process outsourcing-services. Cognizant werkt in nauw partnerschap met ’s werelds grootste organisaties om hun concurrentiepositie te versterken. Het hoofdkantoor is gevestigd in Teaneck, New Jersey (Verenigde Staten). Cognizant combineert een passie voor klanttevredenheid, technologische innovatie en diepgaande industrie- en bedrijfsproceskennis met een wereldwijd samenwerkend personeelsbestand. Cognizant heeft wereldwijd meer dan 100 ontwikkel- en delivery-centers en ongeveer 218.000 werknemers (per 30 juni, 2015). Cognizant heeft een NASDAQ-100 en S&P 500-notering en is verder genoteerd in de Forbes Global 2000 en Fortune 500. De organisatie behoort hiermee tot de best presterende en snelstgroeiende bedrijven in de wereld. Bezoek onze website
www.cognizant.com of volg ons via Twitter: @Cognizant.
Forward-Looking Statements
This press release includes statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, our expectations regarding opportunities in the marketplace and our anticipated financial performance, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ materially from those expressed or implied include general economic conditions and the factors discussed in our most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Cognizant undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities law.
Voor meer persinformatie kunt u contact opnemen met:
OCTANE PR
Tel: +31 (0)40 266 1130
E-mail:
cognizantnl@octanepr.com